Nutrapharm launches Setria-powered supplement, marking a regulatory milestone for the clinically researched ingredient in South America NEW YORK, June 11, 2026 /PRNewswire/ -- Kyowa Hakko, a global leader in health ingredient innovation and manufacturer of branded ingredient Setria Glutathione, today announced that a supplement featuring Setria has been approved for sale in Chile through the Secretara Regional Ministerial (SEREMI) de Salud
Results Study population Informed consent was obtained from 166 patients in period between September 2020 and September 2022, but 10 were excluded because of protocol deviation (poor cooperation)
Gut Inflammation Given that BPC-157 is derived from the human gastric juice protein, there is particular interest in its potential for treating gut-related conditions, such as ulcers and inflammatory bowel disease (IBD, including Crohn's disease and ulcerative colitis)
[3] For BPC-157 and other experimental peptides, the side effect profile is largely unknown due to lack of human clinical trials